Cargando…
Clinical utility of a non-invasive urine test for risk assessing patients with no obvious benign cause of hematuria: a physician-patient real world data analysis
BACKGROUND: The non-invasive Cxbladder urine test system has demonstrated clinical utility in ruling out urothelial carcinoma (UC) in patients with asymptomatic microscopic hematuria (AMH), suggesting that the number of invasive diagnostic tests, including cystoscopy, used in this patient population...
Autores principales: | Lough, Tony, Luo, Qingyang, Luxmanan, Carthika, Anderson, Alastair, Suttie, Jimmy, O’Sullivan, Paul, Darling, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845194/ https://www.ncbi.nlm.nih.gov/pubmed/29523118 http://dx.doi.org/10.1186/s12894-018-0327-6 |
Ejemplares similares
Ejemplares similares
-
Clinical Utility of Cxbladder for the Diagnosis of Urothelial Carcinoma
por: Darling, David, et al.
Publicado: (2017) -
Clinical Utility of Cxbladder Monitor for Patients with a History of Urothelial Carcinoma: A Physician–Patient Real-World Clinical Data Analysis
por: Lough, Tony, et al.
Publicado: (2018) -
A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma
por: Kavalieris, Laimonis, et al.
Publicado: (2015) -
The Use of Molecular Analyses in Voided Urine for the Assessment of Patients with Hematuria
por: Beukers, Willemien, et al.
Publicado: (2013) -
A young man with hematuria and difficulty urinating
por: Urban, Ray, et al.
Publicado: (2021)